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ABSTRACT 
The impaired skeletal muscle of chronic obstructive pulmonary disease (COPD) patients 
reduces exercise capacity. Similar to the oxidative muscle fibers, the angio-adaptation of 
muscle to training may be blunted in these patients, as in other chronic conditions. We 
therefore compared muscle functional responses and angio-adaptations after training in COPD 
patients and sedentary healthy subjects (SHS). 
Twenty-four COPD patients [FEV1 (in %pred.): 45.6±17.5] and 23 SHS (<150 min/week of 
moderate-to-vigorous exercise) completed a 6-week rehabilitation program based on 
individualized moderate-intensity endurance training. Histomorphological muscle analysis 
and measurements of pro-angiogenic vascular endothelial factor-A (VEGF-A) and anti-
angiogenic thrombospondin-1 (TSP-1) were conducted before and after training. 
COPD patients and SHS showed improved symptom-limited oxygen consumption and muscle 
endurance, although improvements were lower in COPD patients (+0.96±2.4 vs. +2.9±2.6 
mL/kg/min, p<0.05 and +65% vs. +108%, p=0.06, respectively). The capillary-to-fiber (C/F) 
ratio increased less in COPD patients than SHS (16±10% vs. 37±20%, p<0.05) and no fiber 
type switch occurred in patients. The VEGF-A/TSP-1 ratio increased in COPD patients and 
SHS (+65% vs. +35%, p<0.05). Changes in C/F and VO2SL were correlated (r=0.51, p<0.05). 
In addition to a lack of fiber switch, COPD patients displayed a blunted angiogenic response 
to training.  
 
Abstract word count: 194 
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INTRODUCTION 
Skeletal muscle dysfunction has substantial implications in many chronic diseases [chronic 
heart failure (CHF), diabetes, peripheral arterial disease [1], obesity, etc.]. In chronic 
obstructive pulmonary disease (COPD), the skeletal muscle dysfunction affects the patient’s 
prognosis, exercise tolerance, and health-related quality of life [2]. This muscle impairment is 
characterized by cellular changes, with decreases in the proportion of type I oxidative fibers, 
oxidative enzymes [3], and capillaries [4]. In particular, the alteration in the capillary supply 
[4] is well-correlated with the impaired muscle function and aerobic exercise capacity of these 
patients.  
 
The impaired skeletal muscle of COPD patients has been associated with physical inactivity 
and, although exercise training is the most efficient therapy for the skeletal muscle 
dysfunction in these patients [5], it has never been able to fully reverse this dysfunction [6]. 
Systemic factors may explain this incomplete recovery [2], but a lack of muscle adaptation at 
the cellular level has also been incriminated. For example, several studies have shown no 
increase in the type I fiber proportion after exercise training in the quadriceps of COPD 
patients [7-10], in contrast to the observations in healthy subjects [11].   
 
Consistent with the role of capillarization in muscle function, it is possible that impaired 
training-induced angiogenesis would also explain the incomplete muscle function recovery in 
COPD patients. Because exercise training significantly increases muscle capillarization in 
these patients [7, 8, 12], it could be hypothesized that the angiogenic response of muscle to 
training is present but blunted in COPD, as in other chronic conditions with similar skeletal 
muscle impairment (diabetes [13] and CHF [14]). Unfortunately, no study has ever compared 
the training-induced capillarization in COPD patients versus sedentary healthy subjects 
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(SHS). Moreover, the impact of COPD on the training-induced expression of the main 
molecular factors controlling skeletal muscle angio-adaptation, such as pro-angiogenic 
vascular endothelial growth factor-A (VEGF-A) or anti-angiogenic thrombospondin-1 (TSP-
1), remains unknown.  
 
Therefore, the aim of our study was to determine whether COPD patients experience a 
specific alteration in their muscle angio-adaptive capacity. To do so, we compared functional 
responses, myofiber remodeling, capillarization, and the main angiogenic factors after a 
moderate-intensity training program in COPD patients and sedentary healthy subjects with the 
same pattern of physical inactivity. 
 
MATERIALS AND METHODS 
See additional information and references in the online supplement. 
 
Study population 
From March 2008 to February 2009, we recruited 24 SHS (age from 50 to 75 years) with no 
disease and less than 150 minutes of moderate-to-vigorous physical activity per week 
(corresponding to the recommended threshold for health improvement [15]) and 24 patients 
with COPD defined by dyspnea, chronic cough or sputum production and/or a history of 
exposure to risk factors for the disease, and post-bronchodilatator FEV1/FVC <70% [16]. 
Exclusion criteria included other respiratory diagnosis, decompensated comorbidity, 
exacerbation in the last 3 months, and previous participation in an exercise training program. 
All subjects and patients performed the tests at INSERM U-1046, CHRU Montpellier, France, 
or “La Solane” and “La Vallonie” Pulmonary Rehabilitation Centers in Osseja and Lodève, 
France, respectively. Informed written consent was obtained from all subjects, and the 
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research protocol was approved by the institutional ethics committee of the Montpellier 
University Hospitals (n° 2008-EESSS-V2 and n°2009-04-BPCO-V2) and conducted in 
accordance with the Helsinki declaration and the European guidelines for “good clinical 
practice. 
 
Physical activity 
In order to assess the physical activity (PA) of our sedentary-selected healthy population, we 
used the Voorrips questionnaire (modified Baecke’s questionnaire), a PA questionnaire 
validated and used in this indication [17]. “Objective” PA level was assessed in 20 COPD 
patients and 20 SHS who wore a triaxial accelerometer (Tritrac RT3 Research Tracker, 
Stayhealthy, Monrovia, CA, USA), validated in COPD [18], for 7 consecutive days. 
The QUANTAP interview-administered survey is a computer-assisted tool designed to 
determine PA over a lifetime in 4 dimensions (sports at school, leisure sports, occupation, and 
daily activities). This questionnaire is reliable to assess lifetime PA and has been validated for 
use in elderly French subjects and in the context of various pathologies, recently in COPD 
[19]. 
 
Pulmonary function tests 
All subjects underwent whole body plethysmography (Transmural Bodybox 2800; 
Sensomedics, Yorba Linda, CA, USA). The values were compared with normal values [20] 
(see online supplement).  
 
Exercise testing and muscle function assessment 
The 6-minute walking test (6MWT) was performed in a 30-meter corridor. The distance 
walked during the test (6MWD) was compared with the reference values [21]. Participants 
performed an incremental test on an electrically-braked cycle ergometer (Ergoselect 200P, 
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Ergolyne, Bitz, Germany) to determine symptom-limited oxygen consumption (VO2SL) and 
the ventilatory threshold [22] (see online supplement). If the ventilatory threshold could not 
be detected, we assessed the dyspnea threshold by rating breathlessness every minute of the 
test, using the patient’s own vocabulary (see online supplement) [23] (see online supplement). 
The quadriceps strength and endurance were measured by isometric maximal voluntary 
contraction (qMVC) and endurance time (T.lim). Fat-free and muscle mass were estimated 
with multi-frequency bioelectrical impedancemetry (QuadScan 4000, Bodystat, Isle of Man, 
UK). Additional information is provided in the online supplement.  
 
Exercise training 
The exercise training sessions were part of a multi-component and comprehensive pulmonary 
rehabilitation course, including an education program [5]. Twenty sessions of endurance 
exercise were conducted 3 or 4 times per week for 6 weeks. The exercise intensity was set as 
the heart rate at the ventilatory or dyspnea threshold [5, 22, 23]. Each session lasted 45 
minutes, and in 1 out of 2 sessions, was followed by 30 minutes of strength-building exercise 
performed at 40% of the one-repetition maximum (1-RM). All sessions were supervised by an 
experienced clinician, and the training intensity was increased during the training protocol. 
 
Muscle biopsy analysis 
Muscle biopsies were performed in the vastus lateralis of the quadriceps before the exercise 
training program and 48 hours after the last training session [24]. 
 
Muscle immunohistochemistry 
Muscle fiber type and mean cross-sectional area (CSA) were assessed after 
immunohistochemistry on frozen sections (10-µm thickness) from the muscle biopsies, using 
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antibodies specific to each myosin heavy chain (MHC) isotype (University of Iowa, IO, USA) 
[4, 25]. Capillaries were visualized by immunochemistry with the monoclonal antibody 
against CD31 (BD Bioscience, #550389, Franklin Lakes, NJ, USA). CSA, capillary density 
and the capillary-to-fiber ratio were determined after counting capillaries and myofibers on 1 
to 2 cryosections from each muscle biopsy (see online supplement). 
 
Western blotting 
Blots were probed for vascular endothelial growth factor-A (VEGF-A, clone VG-1, Millipore 
#05-1117, Etobicoke, ON, Canada) and thrombospondin-1 (TSP-1, clone A6.1, Invitrogen 
#399300, Burlington, ON, Canada). β-actin protein was also measured as our loading control 
(see online supplement). 
 
Statistical analysis 
Data are presented as mean ± SD. Distribution normality was tested by the Kolmogorov-
Smirnov test. Pearson coefficients describe the correlations. We used a multiple linear 
regression model. Comparisons of the training effect between groups were performed by 
mixed linear regression modeling [26]. Each patient/subject was evaluated twice (repeated 
measures). Thus, measured variables were adjusted using a linear mixed-effects model for 
repeated measures to take into account the repeated measures as random variables. Patient 
group and time of measure were used as fixed effects in the model. The group effect was then 
tested with the mixed-linear model. A p-value of <0.05 was considered statistically 
significant. Data were analyzed using R.2.13.0 software.  
 
 
RESULTS 
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Baseline characteristics of the COPD patients and SHS 
All the SHS had a Voorrips score below 9.4, indicating that they were all sedentary. The 
COPD patients and SHS were well-matched according to age and physical activity (PA) level 
(Table 1). Moreover, there was no significant difference between the COPD patients and SHS 
for their PA level over the past 15 years (in metabolic equivalents: 14949±9470 vs. 
12341±5201, p=0.26). At the morphological level (Figure E1, online supplement), COPD 
muscle presented a significantly lower proportion of type I fibers compared with that of SHS 
(Table 2). Additional details are provided in the online supplement.  
 
Exercise training-induced functional and histomorphological adaptations 
Exercise training was performed at the intensity of the ventilatory or dyspnea (n=6/24 COPD 
patients) threshold (mL/kg/min and % of predicted VO2SL) in COPD patients and SHS: 
12.7±1.9, 48.7±11.4% and 15.4±3.5, 63.5±10.1%, respectively; p<0.001. Expressed in % of 
maximal heart rate, the relative intensity was not significantly different in COPD patients and 
SHS (66±6.8% and 69±6.3%, respectively, p=0.27). Expressed in % of VO2SL, the relative 
intensity was slightly higher in COPD patients vs. SHS (66±6% vs. 60±5%, respectively; 
p=0.05). Relative improvements for all functional parameters are shown in Figure 1. The 
training significantly improved 6MWD (m) in both groups (COPD: +37±35 and SHS: 
+31±35, p<0.001; Figure 1). The VO2SL showed significant interaction between group and 
time (p<0.05). Last, a significant increase in T.lim (s) occurred in both groups (COPD: 
+121±169 and SHS +334±274, p<0.001), with an interaction between group and time that 
almost reached significance (p=0.06). 
 
Representative changes in type I fiber proportions in COPD patients and SHS are depicted in 
Figure 2A. The type I fiber proportion was significantly increased in the SHS group 
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(+8±11.6%, p<0.01; Figure 2C) and was mirrored by a decrease in the percentage of type IIx 
fibers (-8±10.0%, p=0.001). Conversely, no significant change occurred in the COPD group 
(Figure 2B). We observed a reduction in fiber CSA in COPD patients (5107±1375 to 
4565±1477 µm², p<0.05) and no significant change in the SHS group (4409±1679 to 
4629±1670, p=0.51). Both type I and type IIa fiber CSA showed this reduction in COPD 
patients (5905±1588 to 5260±1493, p<0.05, and 5400±2012 to 4657±1460, p<0.05).  
 
Exercise training-induced muscle angio-adaptations 
Capillaries were visualized after immunodetection of the endothelial marker CD31 (Figure 
3A). In both groups, the exercise training stimulated angiogenesis, as reflected by the increase 
in the capillary-to-fiber ratio (COPD: 16±10% and SHS: 37±20%, p<0.001; Figure 3B.). Yet 
there was a significant interaction between group and time (p<0.01), indicating lower 
improvement in COPD patients. An improvement in capillary density was observed in both 
groups (COPD: 29±28% and SHS: 9±17%, p<0.01), with no group-time interaction (p=0.11). 
 
Exercise training had no significant effect on the VEGF-A protein level in either healthy 
subjects or COPD subjects. TSP-1 protein expression decreased in response to exercise 
training in both groups (p<0.05) with a 44% decrease observed in the COPD population 
(0.134±0.022 in pre-training vs. 0.075±0.013 in post-training, p<0.05; Figure 4D). 
Interestingly, the VEGF-A/TSP-1 ratio was significantly increased by exercise training in 
both the COPD and SHS groups (+65% and +35%, respectively, p<0.05; Figure 4E), in favor 
of an angiogenic response. 
 
Angiogenesis-function relationships 
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At baseline, the capillary-to-fiber ratio was significantly and positively correlated with VO2SL 
and qMVC in COPD patients and SHS (r=0.60, p<0.01 and r=0.67, p<0.01, Figures 5A and 
5B). The capillary density was not significantly correlated with the type I fiber proportion 
(p=0.07). The absolute training-induced changes in the capillary-to-fiber ratio was 
significantly correlated with the changes in VO2SL in both groups (r=0.51, p<0.05; Figure 5C). 
 
DISCUSSION 
The major finding of our study was that the skeletal muscle in COPD patients showed a 
blunted response to training in terms of muscle capillarization response, which was linked 
with the lower functional improvements. We also observed an increase in the VEGF-A/TSP-1 
ratio in the two groups, in favor of an angiogenic process. Last, a lack of fiber type switch 
response to training was observed in the COPD patients compared with the age- and PA-
matched healthy subjects.  
 
Effect of the training stimulus 
Our program of exercise training at moderate intensity significantly increased the exercise 
capacity in both COPD patients and SHS. Additional details are provided in the online 
supplement. Interestingly, there was a significant interaction between group and time effects 
for VO2SL and T.lim, indicating that the functional changes were lower in the COPD patients 
for these parameters. These lower functional improvements in COPD patients compared with 
SHS are compatible with the lack of exercise-induced muscle fiber type changes [27].  
 
Regarding the exercise training intensity, all participants were trained at their own ventilatory 
(or dyspnea) threshold, which is a method for targeting the training stimulus to the individual 
muscle aerobic capacity [28]. The relative intensity was similar in terms of the percentage of 
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maximal heart rate, which is another classical method to target relative exercise intensity [5, 
22]. Studying trained and untrained healthy subjects, it has appeared that the relative but not 
the absolute intensity was the determinant of the level of transcriptional activation of muscle 
genes in response to exercise training [29]. Greater muscle responses after continuous 
exercise performed at similar relative intensity (50 and 65% of the VO2SL) have even been 
observed in COPD patients compared with healthy subjects, especially for PGC-1α, which is 
a master regulator of the fiber type switch [30]. Thus, in our study, it is very likely that at the 
muscle level, the training stimulus was at least similar in COPD patients and SHS.   
 
Muscle histomorphological and functional responses to training in COPD patients   
In agreement with previous works, the baseline level of muscle capillarization was lower in 
COPD patients [4, 7] and well-correlated with the muscle dysfunction and O2 consumption 
before training [4]. We observed an increase in the capillary-to-fiber ratio, which may indicate 
a training-induced improvement in the capacity to transfer O2 to myofibers in both COPD 
patients and SHS. Indeed, recent work has shown that the O2 transfer to the cell is mostly a 
function of the capillary-to-fiber interface [31], as reflected by the capillary-to-fiber ratio [32]. 
This was highlighted by many of our cryosections, which showed an increase in the length of 
the capillary contact and thus the length of the interface (Figure 3A).  
 
Moreover, the increase in the muscle capillary-to-fiber ratio (i.e., the capillary-to-fiber 
interface, and thus the O2 transfer capacity) may have functioned as a master-driver of muscle 
O2 uptake and thus improved the endurance after moderate-intensity exercise training in the 
COPD patients. This would be consistent with evidence showing the critical role of O2 
transfer to cells across capillaries in the maximal O2 uptake of muscle from healthy subjects 
[33]. Indeed, in our study, we found no change in the capacity of myofibers to consume O2. In 
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contrast to SHS [34], COPD patients showed no shift toward more oxidative type I fibers [7, 
12], and the preliminary data in our COPD patients (n=10) indicated no improvement in the 
maximal rates of oxygen consumption of permeabilized fibers (see Methods and Results in 
the  online supplement). Last, the significant and positive correlation between the capillary-to-
fiber ratio and the VO2SL changes, as previously observed in healthy subjects [35], strengthens 
the credibility of a role for capillarization in the improvement of maximal O2 uptake in our 
COPD patients.  
 
Training-induced response of the angiogenic factors in COPD patients  
Angiogenesis is a complex and multi-step biological process tightly orchestrated by a balance 
between pro- and anti-angiogenic factors. Therefore, we chose to target key pro- and anti-
angiogenic factors with a well-characterized clinical impact, i.e., VEGF-A [36] and TSP-1. 
The deletion of VEGF-A in the myofibers from transgenic mice dramatically reduced muscle 
capillarization and decreased exercise endurance time by approximately 80% [37]. Gene 
therapy targeting VEGF gene expression improved muscle capillarization [38]. TSP-1 is a 
large matrix glycoprotein whose action principally serves to inhibit angiogenesis [36]. Its 
clinical impact has been highlighted by increased muscle capillarity and 67% greater 
endurance in mice knocked out for the TSP-1 gene compared with wild-type [39]. Altogether, 
the VEGF-A/TSP-1 ratio has emerged as the most relevant marker of the muscle angio-
adaptive balance [36]. After hindlimb unloading [40], an increase of the VEGF-A/TSP-1 ratio 
was observed, consistent with the capillarization increase. Thus, assessing the VEGF-A/TSP-
1 ratio appears to be a more accurate approach than analyzing the expression of molecular 
factors individually [36]. In our study, we also observed a significant increase in this ratio in 
both groups, which indicates that the angiogenic balance in our patients shifted in favor of 
angiogenesis, consistent with the capillarization increase.  
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Which mechanisms for the impaired muscle cellular responses to training in COPD patients? 
The defective muscle adaptation to exercise training in COPD patients was characterized by a 
lack of fiber type shift and a blunted capillarization response. Thus, we can hypothesize a 
pleiotropic patho-biological mechanism. In COPD, systemic factors (hypoxemia, oxidative 
stress or systemic low-grade inflammation – all enhanced during exercise) have already been 
incriminated in the peripheral muscle dysfunction [2]. Nonetheless, a molecular link between 
the cellular pathways regulating muscle angiogenesis and the fiber type cannot be eliminated. 
 
Clinical implications 
A key observation in our study was the link between reduced function (quadriceps T.lim and 
VO2SL) and capillarization. Moreover, our study indicates a probable role of the blunted 
muscle capillarization response to training in the reduced VO2SL improvement in the COPD 
patients, as angiogenesis has also shown an impact on the improvement in VO2SL in two other 
chronic diseases: CHF [41] and peripheral arterial disease [42]. Our finding of lower 
improvement in the capillary-to-fiber ratio thus appears to be clinically significant. The 
blunted angiogenic capacity in COPD muscle is consistent with observations in other chronic 
diseases with similar peripheral muscle dysfunction (diabetes [13] and CHF [14]). In diseases 
associated with lower limb ischemia, muscle angiogenesis may thus be a relevant target for 
therapeutic interventions designed to improve muscle capillarization [43]. However, although 
O2 transfer to muscle appears to be critical, there is no evidence of chronic lower limb 
ischemia in COPD patients [44]. Nonetheless, patients with hypoxemia and/or co-morbidities 
(vascular and/or diabetic) can experience chronic ischemia and in this case therapeutic 
interventions in association with exercise training might be an adequate approach. 
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In conclusion, exercise training increased the muscle capillarization in COPD patients, which 
might have driven the functional improvements. Although the most relevant parameter of the 
angio-adaptative balance (i.e., the VEGF-A/TSP-1 ratio) increased in favor of an angiogenic 
process in the COPD patients and SHS, the increase in capillarization was nevertheless 
significantly blunted in the patients. In addition to the lack of fiber type switch, reduced 
angiogenesis constitutes another feature of the altered muscle response to training in COPD 
patients.  
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FIGURE LEGENDS 
Figure 1. Relative changes in functional parameters (%) in chronic obstructive pulmonary 
disease (COPD) patients (dark) and sedentary healthy subjects (SHS) (white) following 
exercise training. 6MWD (m): 6-minute walking distance in meters; 6MWD (%pred.): 6-
minute walking distance in percentage of the predicted value; VO2SL (mL/kg/min): peak 
oxygen uptake in milliliters per kilogram and per minute; T.lim (s): endurance time in 
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seconds; qMVC: quadriceps maximal voluntary contraction in kilograms; BMI: body mass 
index (kg/m²); FFMI: fat-free mass index in kilograms. Data are presented as mean ± standard 
error of the mean. Statistical differences: * time effect, p<0.001; # group-time interaction, 
p<0.05. 
 
 
Figure 2. A) Representative transverse cryosections of the vastus lateralis stained with the 
type I myosin heavy chain isotype antibody at a magnification of * 10, in a COPD patient and 
an SHS before and after exercise. Note the increase in the proportion of type I MHC fibers in 
the SHS. B) Proportion of the muscle fiber type (%) before (dark) and after (white) the 
exercise training program in COPD patients (n=21) and C) SHS (n=23). Data are presented as 
mean ± standard error of the mean. * p<0.05, after exercise training. 
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Figure 3. A) Representative pictures of vastus lateralis capillarization after staining for the 
endothelial marker CD31 at a magnification of  * 10, in a COPD patient and an SHS before 
and after exercise. Note the transverse capillaries surrounding the myofiber (black arrows) in 
pre-exercise training and the increased size of the capillary-to-fiber interface post-exercise 
training (dotted arrows). B) Mean values and standard error of the mean in COPD patients 
and SHS before (dark) and after (white) training for the capillary-to-fiber ratio. * p<0.05, after 
exercise training. # p<0.05, between groups. 
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Figure 4. Representative Western blot of vascular endothelial growth factor-A (VEGF-A) and 
thrombospondin-1 (TSP-1) (respectively, panels A and B) protein expression in the vastus 
lateralis of COPD patients and SHS before (dark) and after (white) training. β-actin is used as 
a loading control. Densitometry analysis of VEGF-A (C) and TSP-1 (D) protein and the 
VEGF-A/TSP-1 ratio (E) in the vastus lateralis of COPD patients and SHS before (dark) and 
after (white) training. Mean ± standard error of the mean. Statistical difference after training: 
* p<0.05; between groups (post-training): ** p<0.05. 
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Figure 5. A) The capillary-to-fiber ratio was positively correlated with the peak oxygen 
uptake (VO2SL), expressed in milliliters per kilogram and per minute (r=0.60, p<0.01), in 
COPD patients (dark) and SHS (white), and B) with the quadriceps maximal voluntary 
contraction (qMVC) expressed in kilograms (r=0.67, p<0.01). C) The capillary-to-fiber ratio 
changes were positively correlated with the changes in peak oxygen uptake (VO2SL), 
expressed in milliliters per kilogram and per minute (r=0.51, p<0.05), in COPD patients 
(dark) and SHS (white). 
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TABLES 
Table 1. Baseline clinical and functional characteristics of the chronic obstructive pulmonary 
disease (COPD) patients and the sedentary healthy subjects (SHS) 
 COPD patients SHS p 
n  24 23 1.00 
Age (y)  60.8 ± 8.0 61.5 ± 5.7 0.756 
Gender (M/F)  18/6 11/12  
FEV1/VC (%) 42.3 ± 8.9 75.8 ± 4.3 <0.001 
FEV1 (%pred.)  45.6 ± 17.5 106.0 ± 12.9 <0.001 
VC (%pred) 90.0 ± 23.7 111.5 ± 14.3 <0.01 
RV (%pred.) 183.8 ± 26.3 114.1 ± 34.6 <0.001 
RV/TLC (%) 52.6 ± 12.2 37.9 ± 6.0 <0.01 
FRC (%pred) 156.7 ± 22.2 109.7 ± 22.3 <0.001 
PaO2 (mmHg) 72.1 ± 10.1 -  
PA level  
(Voorrips score)  
6.3 [2.5-7.9] 4.3 [3.2-5.6] 0.474 
PA level  
(activity counts, AU)  
123 ± 44 
(n=9) 
137 ± 51 
(n=19) 
0.490 
6MWD (m)  480 [426-568] 615 [580-652] <0.001 
6MWD (%pred.)  70.4 ± 16.2 93.4 ±10.5 <0.001 
VO2SL (mL/kg/min)  16.8 ± 5.0 25.7 ± 6.0 <0.001 
VO2SL (%pred.)  64.1 ± 20.2 107.7 ± 13.8 <0.001 
BMI (kg/m²)  24.7 ± 4.1 25.9 ± 2.8 0.285 
FFMI (kg/m²)  18.1 ± 2.0 18.9 ± 2.9 0.287 
qMVC (kg)  17.6 ± 5.6 21.7 ± 9.0 0.105 
Quadriceps T.lim (s) 272 [159-368] 340 [221-656] 0.05 
 
Definition of abbreviations: M: male/F: female; FEV1 (%pred.): forced expiratory volume in 1 
second in percentage of the predicted value; VC (% pred.): slow vital capacity, in percentage 
of the predicted value; RV (%pred.): residual volume, in percentage of the predicted value; 
RV/TLC (%): ratio of the residual volume and total lung capacity, in percentage; FRC (% 
pred.): functional residual capacity, in percentage of the predicted value; PA: physical 
activity; 6MWD (m): 6-minute walking distance, in meters; 6MWD (%pred.): 6-minute 
walking distance, in percentage of the predicted value; VO2SL (mL/kg/min): peak oxygen 
uptake, in milliliters per kilogram and per minute; BMI: body mass index (kg/m²); FFMI: fat-
free mass index (kg/m²); qMVC (kg): quadriceps maximal voluntary contraction, in 
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kilograms; T.lim (s): quadriceps endurance time, in seconds. Results are expressed in mean ± 
SD or median [interquartile range (IQR)].  
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Table 2. Muscle characteristics of the chronic obstructive pulmonary disease (COPD) patients 
and the sedentary healthy subjects (SHS) 
 COPD patients SHS p 
n  24 23  
Muscle fiber %     
Type I  37.5 ± 12.6 44.5 ± 11.1 <0.05 
Type I/IIa  2.1 ± 4.1 0.8 ± 0.8 0.118 
Type IIa  26.4 ± 15.9 22.2 ± 14.0 0.356 
Type IIa/IIx  20.0 ± 13.5 19.5 ± 12.1 0.886 
Type IIx  13.8 ± 10.8 13.0 ± 8.6 0.784 
All fiber cross-sectional 
area (µm²)  
5107 ± 1376 4409 ± 1679 0.141 
Capillary-to-fiber ratio  1.273 ± 0.247 
(n=10) 
1.625 ± 0.327 
(n=8) 
<0.05 
Capillary density (/mm²) 256 ± 539 
(n=10) 
309 ± 557 
(n=8) 
0.057 
 
Results are expressed in mean ± SD 
